Sale!

Oncomine Myelodysplastic Syndrome MDS Panel Test

8,190 د.إ

-10%

The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a cutting-edge diagnostic tool designed to provide comprehensive genetic insights into myelodysplastic syndromes, a group of bone marrow disorders characterized by the bone marrow’s inability to produce enough healthy blood cells. Conducted at DNA Labs UAE, this test utilizes next-generation sequencing technology to analyze multiple genes simultaneously, enabling the identification of specific genetic mutations associated with MDS. This information is crucial for the precise diagnosis, prognosis, and tailoring of treatment plans for individuals with MDS.

The test is priced at 8190 AED, reflecting the advanced technology and expertise required to perform this sophisticated analysis. By pinpointing specific genetic abnormalities, the Oncomine MDS Panel Test helps healthcare professionals make more informed decisions regarding patient care, potentially leading to improved treatment outcomes. DNA Labs UAE, known for its commitment to quality and accuracy, ensures that this test is conducted under stringent quality controls, providing reliable and timely results for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test

Test Name: ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test

Test Components: ASXL1, BCOR, CBL, CEBPA, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS, MECOM, MYC, MPL, NRAS, NF1, NPM1, PHF6, PPRF8, PTPN11, PHF6, RUNX1, SF3B1, SRSF2, SMC1A, SH2B3, STAG2, TP53, TET2, U2AF1, WT1, ZRSR2

FUSION GENE: ETV6, JAK2, KMT2A, MLL, MECOM, RARA, RUNX1

Price: 8190.0 AED

Sample Condition: 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Form is mandatory.

Report Delivery: Sample by 1st / 16th of every month; Report 15th / 30th of Same month

Method: NGS (Next Generation Sequencing)

Test Type: Leukemia

Doctor: Hematologist, Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.

Test Details

The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a diagnostic tool used to detect genetic mutations in patients with MDS, a group of disorders in which the bone marrow produces abnormal blood cells. The test analyzes DNA from a patient’s blood or bone marrow sample and identifies mutations in 28 genes that are commonly associated with MDS. These mutations can help doctors make a more accurate diagnosis and determine the best course of treatment for the patient. The Oncomine MDS Panel Test is a non-invasive, fast, and accurate way to diagnose MDS, and it can help patients get the care they need as quickly as possible.

Test Name ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test
Components ASXL1, BCOR, CBL, CEBPA,DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,MECOM, MYC, MPL, NRAS, NF1, NPM1, PHF6, PPRF8, PTPN11,PHF6, RUNX1, SF3B1, SRSF2, SMC1A, SH2B3, STAG2, TP53, TET2, U2AF1, WT1, ZRSR2FUSION GENE -ETV6, JAK2, KMT2A, MLL, MECOM , RARA, RUNX1,
Price 8190.0 AED
Sample Condition 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Method NGS
Test type Leukemia
Doctor Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a diagnostic tool used to detect genetic mutations in patients with MDS, a group of disorders in which the bone marrow produces abnormal blood cells. The test analyzes DNA from a patient’s blood or bone marrow sample and identifies mutations in 28 genes that are commonly associated with MDS. These mutations can help doctors make a more accurate diagnosis and determine the best course of treatment for the patient. The Oncomine MDS Panel Test is a non-invasive, fast, and accurate way to diagnose MDS, and it can help patients get the care they need as quickly as possible.